Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)

BACKGROUND: Direct-acting antivirals can cure hepatitis C virus (HCV). Persons with HCV/HIV and living with substance use are disadvantaged in benefiting from advances in HCV treatment. METHODS: In this randomized controlled trial, participants with HCV/HIV were randomized between February 2016 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Metsch, Lisa R, Feaster, Daniel J, Gooden, Lauren K, Masson, Carmen, Perlman, David C, Jain, Mamta K, Matheson, Tim, Nelson, C Mindy, Jacobs, Petra, Tross, Susan, Haynes, Louise, Lucas, Gregory M, Colasanti, Jonathan A, Rodriguez, Allan, Drainoni, Mari-Lynn, Osorio, Georgina, Nijhawan, Ank E, Jacobson, Jeffrey M, Sullivan, Meg, Metzger, David, Vergara-Rodriguez, Pamela, Lubelchek, Ronald, Duan, Rui, Batycki, Jacob N, Matthews, Abigail G, Munoz, Felipe, Jelstrom, Eve, Mandler, Raul, del Rio, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339611/
https://www.ncbi.nlm.nih.gov/pubmed/34377726
http://dx.doi.org/10.1093/ofid/ofab334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339611/
https://www.ncbi.nlm.nih.gov/pubmed/34377726
http://dx.doi.org/10.1093/ofid/ofab334

Ejemplares similares